Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05781100 · ClinicalTrials.gov registry record · NA

Investigating Baby Behavior and Family Technology Use Study

A NA study of Infant Development and Self-regulation, sponsored by California Polytechnic State University-San Luis Obispo.

Recruiting
Registry status
NA
Development phase
345
Enrollment target
1
Study location

NCT05781100: Recruiting NA study of Infant Development and Self-regulation, sponsored by California Polytechnic State University-San Luis Obispo.

NCT05781100 is a NA study of Infant Development and Self-regulation that is actively recruiting participants, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 345 participants, below the 391-participant average among 30 other Infant Development trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05781100, a NA study of Infant Development and Self-regulation, is actively recruiting participants, sponsored by California Polytechnic State University-San Luis Obispo.

RECRUITING
Registry status
NA
Development phase
345 participants
Enrollment target
1
Study location

Study Summary

Maternal sensitivity and contingent responsiveness to infant behavioral cues is an important contributor to infants' developing capacities to self-regulate. During early infancy, feeding interactions comprise a significant portion of mother-infant dyadic interactions and high-quality feeding interactions provide both nutritive and socioemotional benefits; recent data suggest that, for many dyads, mothers' sensitive responsiveness during feeding interactions is routinely impacted by the omnipresence of portable technology. The objective of the proposed research is to better understand the development and possible impacts of maternal technology use on infant feeding interactions, emotion and intake regulation, and sociobehavioral and growth outcomes.

Primary Outcome

When infants are 1 month and 4 months of age, mother-infant dyads will be observed during 3 within-subject experimental feeding conditions: TV Use, Mobile Device Use, or Control. Videos of feeding interactions will be later coded using the Nursing Child Assessment Parent-Child Interaction Feeding Scale (NCAFS). Possible score range for the Maternal Sensitivity to Infant Cues subscale is 0-16 with higher scores representing greater maternal sensitivity to infant cues.

Interventions

  • BEHAVIORAL Technology Use during Feeding Conditions

Study Locations (1)

California

  • California Polytechnic State University - San Luis Obispo

Trial Details

FieldValue
Enrollment Target 345 participants
Start Date 2023-01-16
Est. Completion 2027-06-30
Phase NA

What NCT05781100 shows while recruiting

NCT05781100 is an interventional study that assigns participants to a tested intervention. The registered 345 participants enrollment target is mid-sized for trials with a published cap, below the 391-participant average among 30 other Infant Development trials with a reported enrollment target (12% lower).

The record links to 5 conditions, with Infant Development appearing as the primary indexed condition, and to 1 intervention - of which Technology Use during Feeding Conditions is the first listed.

NCT05781100 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05781100 about?

NCT05781100 is a clinical study titled "Investigating Baby Behavior and Family Technology Use Study". Maternal sensitivity and contingent responsiveness to infant behavioral cues is an important contributor to infants' developing capacities to self-regulate. During early infancy, feeding interactions comprise a significant portion of mother-infant dyadic interactions and high-quality feeding interac...

What is the current status of trial NCT05781100?

This trial is currently recruiting. It is a NA study. The enrollment target is 345 participants. The study started on 2023-01-16. Estimated completion is 2027-06-30.

What conditions does trial NCT05781100 study?

This clinical trial studies the following conditions: Infant Development, Self-regulation, Mother-Infant Interaction, Mobile Phone Use, Self-Regulation, Emotion.

What interventions are being tested in trial NCT05781100?

The interventions under investigation include: Technology Use during Feeding Conditions (BEHAVIORAL).

Who is sponsoring clinical trial NCT05781100?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05781100 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05781100's enrollment target sits among peer trials

345 6th of 30 higher than 25 of 30 other Infant Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03972657 · 345 participants · Phase 1

    A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

  • NCT05107674 · 345 participants · Phase 1

    A Study of NX-1607 in Adults With Advanced Malignancies

  • NCT05700279 · 345 participants · NA

    Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset

  • NCT06884618 · 345 participants · Phase 1

    A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05781100, the US trial registry maintained by the National Library of Medicine. NCT05781100 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.